ZRANB1 and neoplasm: While treatment of Trabid inhibitor or anti-PD-1 antibody alone decreased tumor growth and tumor weight, and prolonged mice survival, the combined treatment offered significantly improved therapeutic effects compared with single treatment (Fig. 7b–d and Supplementary Fig. 7c).